Invivyd (IVVD) Competitors

SOPHiA GENETICS (NASDAQ:SOPH) and Invivyd (NASDAQ:IVVD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, community ranking, analyst recommendations, valuation, institutional ownership and dividends.

Do analysts prefer SOPH or IVVD?

SOPHiA GENETICS currently has a consensus price target of $8.00, indicating a potential upside of 66.67%. Invivyd has a consensus price target of $11.33, indicating a potential upside of 372.22%. Given SOPHiA GENETICS's higher probable upside, analysts plainly believe Invivyd is more favorable than SOPHiA GENETICS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Invivyd	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has stronger earnings & valuation, SOPH or IVVD?

SOPHiA GENETICS has higher revenue and earnings than Invivyd. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than Invivyd, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$62.37M	5.02	-$78.98M	-$1.22	-3.93
Invivyd	N/A	N/A	-$198.64M	-$1.81	-1.30

Does the MarketBeat Community prefer SOPH or IVVD?

SOPHiA GENETICS received 10 more outperform votes than Invivyd when rated by MarketBeat users. Likewise, 72.73% of users gave SOPHiA GENETICS an outperform vote while only 60.00% of users gave Invivyd an outperform vote.

Company	Underperform	Outperform
SOPHiA GENETICS	Outperform Votes 16 72.73%	Underperform Votes 6 27.27%
Invivyd	Outperform Votes 6 60.00%	Underperform Votes 4 40.00%

Do insiders & institutionals believe in SOPH or IVVD?

31.6% of SOPHiA GENETICS shares are owned by institutional investors. Comparatively, 70.4% of Invivyd shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by insiders. Comparatively, 19.1% of Invivyd shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is SOPH or IVVD more profitable?

Invivyd has a net margin of 0.00% compared to Invivyd's net margin of -126.63%. Invivyd's return on equity of -47.40% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-126.63%	-47.40%	-36.43%
Invivyd	N/A	-76.97%	-67.91%

Which has more risk & volatility, SOPH or IVVD?

SOPHiA GENETICS has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Invivyd has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.

Does the media favor SOPH or IVVD?

In the previous week, Invivyd had 2 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 7 mentions for Invivyd and 5 mentions for SOPHiA GENETICS. Invivyd's average media sentiment score of 0.31 beat SOPHiA GENETICS's score of -0.18 indicating that SOPHiA GENETICS is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SOPHiA GENETICS	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Invivyd	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

SOPHiA GENETICS beats Invivyd on 9 of the 16 factors compared between the two stocks.